OMRON Healthcare Highlights the Risks of Undiagnosed Heart Failure in Women at ESC Congress 2025
OMRON Healthcare Co., Ltd., known globally as a highly recommended brand for blood pressure monitors by healthcare professionals, recently revealed its participation in the prestigious ESC Congress 2025, taking place in Madrid, Spain from August 29 to September 1. This annual gathering serves as a key platform for cardiology professionals, healthcare technology providers, and associated fields to discuss recent studies and advancements within the cardiovascular realm. OMRON’s ongoing collaboration with the ESC highlights its commitment to leading in the cardiology space once again at this critical event.
Following a successful symposium on atrial fibrillation and hypertension at ESC 2024 in London, OMRON is set to sponsor another pivotal session titled "Unveiling the Hidden Threat: Recognizing Undiagnosed Heart Failure in Women," which will commence at 3:15 PM on August 29. This session will feature acclaimed experts including Alta Schutte from The George Institute for Global Health in Australia, Eva Gerdts from the University of Bergen in Norway, and Renate B. Schnabel from the University Heart and Vascular Centre in Hamburg, Germany.
Despite being the leading cause of death among women globally, cardiovascular diseases often go misdiagnosed and poorly treated, stemming from ingrained biases in research, clinical guidelines, and symptom recognition. A study conducted by OMRON Healthcare in Japan in 2023 highlighted alarming statistics: while approximately 50% of surveyed women had experienced early warning signs such as palpitations and shortness of breath, over half had not consulted a physician and many dismissed their symptoms as mere signs of menopause.
Furthermore, the research revealed that although around half of those surveyed were familiar with atrial fibrillation (AFib)—a common arrhythmia that can lead to serious complications such as blood clots and strokes—most remained unaware of its potential severity and the critical importance of early detection and treatment on long-term health outcomes.
To address these pressing issues, OMRON advocates for regular self-monitoring of blood pressure through devices that integrate with the OMRON connect app, allowing users to analyze patterns and share vital data with their healthcare providers. The company also employs its proprietary Intellisense AFib technology to identify signs of this dangerous condition.
At the ESC 2025 Congress, attendees will have a unique sneak peek at OMRON’s forthcoming line of upper-arm blood pressure monitors, which aim to significantly enhance cardiac health outcomes globally by promoting home monitoring and incorporating proprietary screening technologies. "We are thrilled to return to the ESC Congress this year," expressed Karen Benegmos-Sanders, General Manager of OMRON Healthcare Europe. "In addition to bringing together leading experts in a session that addresses crucial cardiovascular care topics, we are excited to present an advance look at our new line of blood pressure monitors, which we believe can transform health outcomes worldwide."
The satellite symposium, sponsored by OMRON Healthcare Europe B.V., is an essential event aimed at raising awareness about the life-threatening risks of undiagnosed heart failure in women. Key presentations will cover various aspects of this important health topic, including:
For more in-depth information about OMRON Healthcare's contributions at the ESC Congress, please visit the session’s official page. By shining a light on these critical issues, OMRON Healthcare aims to empower women and healthcare professionals alike to prioritize understanding and managing heart health effectively. This initiative is pivotal not only within the conference framework but also in the broader fight against cardiovascular disease, which continues to impact countless lives globally.
For additional resources and developments from OMRON Healthcare, visit their official website and remain updated through their LinkedIn page.
Following a successful symposium on atrial fibrillation and hypertension at ESC 2024 in London, OMRON is set to sponsor another pivotal session titled "Unveiling the Hidden Threat: Recognizing Undiagnosed Heart Failure in Women," which will commence at 3:15 PM on August 29. This session will feature acclaimed experts including Alta Schutte from The George Institute for Global Health in Australia, Eva Gerdts from the University of Bergen in Norway, and Renate B. Schnabel from the University Heart and Vascular Centre in Hamburg, Germany.
Despite being the leading cause of death among women globally, cardiovascular diseases often go misdiagnosed and poorly treated, stemming from ingrained biases in research, clinical guidelines, and symptom recognition. A study conducted by OMRON Healthcare in Japan in 2023 highlighted alarming statistics: while approximately 50% of surveyed women had experienced early warning signs such as palpitations and shortness of breath, over half had not consulted a physician and many dismissed their symptoms as mere signs of menopause.
Furthermore, the research revealed that although around half of those surveyed were familiar with atrial fibrillation (AFib)—a common arrhythmia that can lead to serious complications such as blood clots and strokes—most remained unaware of its potential severity and the critical importance of early detection and treatment on long-term health outcomes.
To address these pressing issues, OMRON advocates for regular self-monitoring of blood pressure through devices that integrate with the OMRON connect app, allowing users to analyze patterns and share vital data with their healthcare providers. The company also employs its proprietary Intellisense AFib technology to identify signs of this dangerous condition.
At the ESC 2025 Congress, attendees will have a unique sneak peek at OMRON’s forthcoming line of upper-arm blood pressure monitors, which aim to significantly enhance cardiac health outcomes globally by promoting home monitoring and incorporating proprietary screening technologies. "We are thrilled to return to the ESC Congress this year," expressed Karen Benegmos-Sanders, General Manager of OMRON Healthcare Europe. "In addition to bringing together leading experts in a session that addresses crucial cardiovascular care topics, we are excited to present an advance look at our new line of blood pressure monitors, which we believe can transform health outcomes worldwide."
The satellite symposium, sponsored by OMRON Healthcare Europe B.V., is an essential event aimed at raising awareness about the life-threatening risks of undiagnosed heart failure in women. Key presentations will cover various aspects of this important health topic, including:
- - Bias in Cardiovascular Care: Alta Schutte, The George Institute for Global Health, Sydney, Australia discusses why cardiovascular conditions often go unrecognized in women.
- - Risks and Symptoms of Female Heart Failure: Eva Gerdts, University of Bergen, elaborates on the unique challenges and symptoms faced by women dealing with heart failure.
- - Early Detection of Atrial Fibrillation: Renate B. Schnabel, University Heart and Vascular Centre Hamburg emphasizes how early diagnosis can positively affect patient outcomes.
For more in-depth information about OMRON Healthcare's contributions at the ESC Congress, please visit the session’s official page. By shining a light on these critical issues, OMRON Healthcare aims to empower women and healthcare professionals alike to prioritize understanding and managing heart health effectively. This initiative is pivotal not only within the conference framework but also in the broader fight against cardiovascular disease, which continues to impact countless lives globally.
For additional resources and developments from OMRON Healthcare, visit their official website and remain updated through their LinkedIn page.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.